This online educational enduring material is designed for primary care physicians, psychiatrists, physician assistants, and nurse practitioners. Its purpose is to address the need for screening, recognizing, and treating major depression in women.
At the end of this online enduring material, participants should be able to:
Demonstrate how objective and subjective complexity indicators can be used for MDD care in women
Show the importance of developing individualized treatment plans for MDD patients that are driven by data, evidence-based guidelines, and patient input
Manage MDD patients with a broad range of treatment strategies
Emphasize a collaborative multidisciplinary approach to patient management
Disclosure of Conflicts of Interest
In order to assure the highest quality of CME programming, and to comply with the ACCME Standards for Commercial Support, Texas Health Research & Education Institute requires that all faculty and planning committee members disclose financial relationships relevant to the content being planned and/or presented. The relevant financial relationships are those they may have with any commercial interest producing health care goods or services consumed by or used on patients. Disclosures are provided below for the CME activity chair, planners and content reviewer.
*Doctors on the medical staff practice independently and are not employees or agents of the hospital except resident doctors in the hospital’s graduate medical education program.
Dr. Secrest has no relevant financial relationship with proprietary entities producing health care goods or services related to the content of this CME activity.
Planning Committee Scott Dahl, MBA, BS Mary Digison, RN Christina Martin Marilyn Peterson, MA, CCMEP Sandra Pinkerton, PhD, CCMEP Gwen Pond Elizabeth Weidmer-Mikhail, MD
The planners have no relevant financial relationship with proprietary entities producing health care goods or services related to the content of this CME activity.
Content Reviewer Madhukar Trivedi, MD Betty Jo Hay Distinguished Chair in Mental Health Professor, Department of Psychiatry University of Texas Southwestern Medical Center Dallas, TX
Dr. Trivedi, has disclosed the following relevant financial relationships with proprietary entities producing health care goods or services related to the content of this CME activity: Receives consulting fees from Abbott Laboratories, Inc., Alkermes, AstraZeneca, Axon Advisors, Bristol-Myers Squibb Company, Cephalon, Inc., Eli Lilly & Company, Evotek, Forest Pharmaceuticals, GlaxoSmithKline, Johnson & Johnson PRD, Lundbeck, MedAvante, Neuronetics, Otsuka Pharmaceuticals, Pamlab, Pfizer, Inc., PgxHealth, Rexahn Pharmaceuticals, SHIRE Development, Takeda, Tal Medical/Puretech Venture, and Transcept. Receives research support from Agency for Healthcare Research and Quality, National Institute of Mental Health, National Institute on Drug Abuse, Naurex, Targacept, and Valient.
AMA PRA Category 1 Credit(s)TM
Texas Health Research & Education Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Texas Health Research & Education Institute designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For full program information, please click on “BEGIN” button and follow the next click-through to reach this program site. Once you get to the “Texas Health Research & Education Institute” description page, you will review program information, program content, take the test, and receive credit.
If you have any questions relating to the accreditation or your certificate for this activity, please contact us at 866-295-3269, ext 1.